Relapse after allogeneic stem cell transplantation: Is it time for routine HLA loss testing?
Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains one of the few potentially...
Same disease, different testing approaches: global survey highlights the need for standardized FH genetic testing
Familial hypercholesterolemia (FH) is a common inherited disorder affecting approximately 1 in 250...
Devyser signs first commercial reagent rental agreement under Illumina collaboration in Italy
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
-1.png)
Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...